期刊文献+

甲钴胺联合单唾液酸神经节苷脂治疗糖尿病周围神经病变临床观察 被引量:1

暂未订购
导出
摘要 糖尿病周围神经病变是糖尿病最常见的慢性并发症之一,其发病与血管功能障碍、代谢紊乱、神经营养因子缺乏、氧化应激等因素密切相关,是糖尿病患者致残主要原因之一。本病的常规治疗是在有效控制血糖的基础上应用B族维生素治疗。本文应用甲钴胺联合单唾液酸神经节苷脂治疗本病,疗效较好,现将结果报告如下。
作者 陈敏
出处 《中西医结合研究》 2015年第5期266-266,共1页 Research of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献2

二级参考文献24

  • 1邵震宇,刘忆林,姜伟.单唾液酸四己糖神经节苷酯治疗帕金森病1例[J].医药导报,2004,23(9):657-657. 被引量:5
  • 2魏晓捷,付小君,许信龙.神经节苷脂治疗重型颅脑损伤的临床观察[J].浙江创伤外科,2001,6(1):19-19. 被引量:3
  • 3郑白蒂 胡国贤 等.糖尿病性神经病变治疗的探讨[J].中华内科杂志,1981,20(9):523-525.
  • 4Li YS,Mahadik SP,Rapport MM,et al.Acute effects of GM1 ganglioside:reduction in both behavioral asymmetry and loss of Na+,K+-ATPase after nigrostriatal transection.Brain Res,1986,377 (2):292-297.
  • 5Doherty P,Ashton SV,Skaper SD,et al.Ganglioside modulation of neural cell adhesion molecule and N-cadherin-dependent ncurite outgrowth.J Cell Biol,1992,117(5):1093-1099.
  • 6Manev H,Favaron M,Vicini S,et al.Ganglioside-mediated protection from glutamate-induced neuronal death.Acta Neurobiol Exp (Wars),1990,50(4-5):475-488.
  • 7Panni MK,Cooper JD,Sofroniew MV.Ganglioside GM1 potentiates NGF action on axotomised medial septal cholinergic neurons.Brain Res,1998,812 (1-2):76-80.
  • 8Mahadik SP,Makar TK,Murthy JN,et al.Temporal changes in surperoxide dismutase,glutathione peroxidase,and catalase levels in primary and peri-ischemictissue.Monosialogangliosides(GM1) treatment effects.Mol Chem Neuropathol,1993,18 (1-2):1.
  • 9Lenzi GL,Grigoletto F,Gent M,et al.Early treatment of stroke with monosialoganglioside GM-1.Efficacy and safety results of the early stroke trial.Stroke,1994,25(8):1552-1558.
  • 10Argentino C,Sacchetti ML,Toni D,et al.GM1 ganglioside therapy in acute ischemic stroke.Stroke,1990,21(5):825.

共引文献46

同被引文献5

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部